TB Alliance’s mission can only be achieved if new and improved TB medicines reach the millions around the world suffering from the disease.
New products must be adopted by global, national, and local regulatory bodies and health systems.
TB Alliance works closely with decision-makers, local health systems and communities to understand local needs, priorities and processes to develop products for people who need them.
New products must reach those in need.
TB Alliance is committed to ensuring that improved TB regimens are available to all who need them around the world. We work to understand markets and partner with manufacturers, distributors and purchasers to ensure consistent supply of our products where they are needed.
TB treatments must be affordable to those with TB and their health systems.
TB Alliance works with partners to ensure new TB regimens are affordable to patients and countries. From prioritizing cost of goods when evaluating early stage research opportunities to fostering a competitive marketplace for our products, we work to ensure that cost isn't a barrier to those in need of the TB cures we develop.
TB Alliance works with partners and stakeholders across a wide range of activities to achieve our "AAA Mandate."